Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
9.66
+0.14 (1.52%)
May 16, 2025, 10:05 AM - Market open
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$727,457
Profits / Employee
-$148,319
Market Cap
1.16B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DVAX News
- 18 hours ago - Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting - Business Wire
- 4 days ago - Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - PRNewsWire
- 8 days ago - Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum - PRNewsWire
- 9 days ago - Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PRNewsWire
- 10 days ago - Deep Track Capital Releases Investor Presentation on Dynavax Technologies - Business Wire
- 15 days ago - Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits - PRNewsWire
- 17 days ago - Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy - PRNewsWire